| Metric | შპს ნეოგენი | შპს ბათუმის ენდოკრინოლოგიის ცენტრი |
|---|---|---|
| Growth | ||
| Revenue | ₾2.3m₾2.1m | ₾2.2m₾1.9m |
| Revenue growth | 8.1% | 14.1% |
| Profitability | ||
| EBITDA | ₾208k₾161k | ₾160k₾267k |
| EBITDA margin | 9.2%7.7% | 7.4%14.0% |
| Net profit | ₾178k₾135k | ₾159k₾265k |
| Net margin | 7.9%6.5% | 7.3%13.9% |
| Balance sheet | ||
| Total assets | ₾369k₾355k | ₾2.1m₾2.2m |
| Total equity | ₾230k₾221k | ₾1.9m₾2.1m |
| ROE | 77.5%61.3% | 8.2%12.7% |